This gene is of significant interest in human NAFLD lipid metabolism, as mutations in ACOX1 lead to elevated plasma concentrations of long straight-chain fatty acids in humans, accompanied by developmental delay, cerebellar ataxia, and language impairment [56,57]. This evidence concerns the gene ACOX1 and metabolic dysfunction-associated steatotic liver disease.